The Impact of PD-L1 and Correlated Markers on the Prognosis of Adenocarcinoma NSCLC Patients

Bian, XY; Wang, JJ; Chen, W; Xu, MD; Xu, CH; Wu, MY; Tao, M

Wu, MY; Tao, M (通讯作者),Soochow Univ, Dept Oncol, Affiliated Hosp 1, Suzhou 215006, Jiangsu, Peoples R China.;Tao, M (通讯作者),Soochow Univ, Dept Oncol, DuShu Lake Hosp, Suzhou 215006, Jiangsu, Peoples R China.

JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2022; 36 (5): 1341

Abstract

Background: Programmed death ligand-1 (PD-L1) status in tumor pathology is a key factor that predicts the response to immune -checkpoint inhibitors (I......

Full Text Link